Predictors of adherence to a new erythropoiesis-stimulating agent inpatient ordering policy: A cross-sectional study.

Numan AlabdanYazed Sulaiman H Al-RuthiaMary E D YatesIbrahim SalesChristopher K FinchJoanna Q Hudson

Published in: PloS one (2017)

Prescribers were adherent to a 5-day delay in the initiation of ESA therapy policy which resulted in a reduction in ESA usage, did not impact the discharge Hb levels, and was proven to be cost effective.

Keyphrases

mental health
public health
healthcare
palliative care
physical activity
risk factors
type diabetes
stem cells
acute care
cell therapy
bone marrow
smoking cessation